Case Reports in Clinical Medicine
Vol.7 No.7(2018), Paper ID 86126, 10
pages
DOI:10.4236/crcm.2018.77039
Prolonged Disease Stabilization and Tolerability in a Nuclear Protein in Testis Midline Carcinoma Patient Treated with Dual Histone Deacetylase and Phosphoinositide 3-Kinase Inhibitor CUDC-907
Pamela Munster, Nilson Wu, Meaghan McMahon, Robert Gharavi, David Tuck
Division of Hematology and Oncology, University of California, San Francisco, USA
Division of Hematology and Oncology, University of California, San Francisco, USA
Curis,Inc.,Lexington,Massachusetts,USA
Curis,Inc.,Lexington,Massachusetts,USA
Division of Hematology and Oncology, University of California, San Francisco, USA
Copyright © 2018 Pamela Munster, Nilson Wu, Meaghan McMahon, Robert Gharavi, David Tuck et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Munster, P. , Wu, N. , McMahon, M. , Gharavi, R. and Tuck, D. (2018) Prolonged Disease Stabilization and Tolerability in a Nuclear Protein in Testis Midline Carcinoma Patient Treated with Dual Histone Deacetylase and Phosphoinositide 3-Kinase Inhibitor CUDC-907.
Case Reports in Clinical Medicine,
7, 451-460. doi:
10.4236/crcm.2018.77039.